BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2417984)

  • 1. Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.
    Driscoll JS; Johns DG; Plowman J
    Invest New Drugs; 1985; 3(4):331-4. PubMed ID: 2417984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
    Kato T; Ota K
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):502-5. PubMed ID: 2949703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileukemic activity of 5-aza-2'-deoxycytidine and cytarabine against intracerebral L1210 murine leukemia.
    Chabot GG; Momparler RL
    Cancer Treat Rep; 1984 Dec; 68(12):1483-7. PubMed ID: 6210142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of 5-azacytosine arabinoside.
    Beisler JA; Abbasi MM; Driscoll JS
    J Med Chem; 1979 Oct; 22(10):1230-4. PubMed ID: 92567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arabinosyl-5-azacytosine: plasma kinetics and therapeutic response (L1210) in vitro and in vivo in mice.
    Zaharko DS; Covey JM
    Invest New Drugs; 1985; 3(4):323-9. PubMed ID: 2417983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia.
    Momparler RL; Momparler LF; Samson J
    Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic mice.
    Wallace RE; Lindh D; Durr FE
    Cancer Chemother Pharmacol; 1989; 25(2):117-23. PubMed ID: 2480854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia.
    Yang GS; McCulloch EA
    Hematol Pathol; 1992; 6(3):125-30. PubMed ID: 1385380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
    Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
    Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
    Momparler RL; Momparler LF; Samson J
    Int J Cancer; 1982 Sep; 30(3):361-64. PubMed ID: 6182115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    VeselĂ˝ J; PĂ­skala A
    Neoplasma; 1986; 33(1):3-10. PubMed ID: 2421173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.
    Presant CA; Vietti TJ; Valeriote F; Coulter DM
    J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-beta-D-arabinofuranosylcytosine-phospholipid conjugates as prodrugs of Ara-C.
    Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Ryu EK; MacCoss M
    Cancer Drug Deliv; 1984; 1(3):181-90. PubMed ID: 6544120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.
    Dalal M; Plowman J; Breitman TR; Schuller HM; del Campo AA; Vistica DT; Driscoll JS; Cooney DA; Johns DG
    Cancer Res; 1986 Feb; 46(2):831-8. PubMed ID: 2416433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine and human leukemias.
    Burchenal JH
    Bibl Haematol; 1975; (40):665-77. PubMed ID: 1100047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
    Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR
    J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids as potential antitumor agents.
    Hong CI; Nechaev A; Kirisits AJ; Buchheit DJ; West CR
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1105-12. PubMed ID: 6684555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
    Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
    J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
    Momparler RL; Momparler LF
    Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.